ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.540
-0.040 (-2.53%)
At close: Jul 31, 2026, 4:00 PM EDT
1.520
-0.020 (-1.30%)
After-hours: Jul 31, 2026, 7:56 PM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $465.17 million as of July 31, 2026. Its market cap has decreased by -40.92% in one year.
Market Cap
465.17M
Enterprise Value
244.01M
1-Year Change
-40.92%
Ranking
Category
Stock Price
$1.54
ChartMarket Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $465.17M, an increase of 79.74%. That is a compound annual growth rate of 12.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 465.20M | -30.97% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
| Jun 30, 2021 | 258.80M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rezolute | 490.99M |
| Cybin | 490.29M |
| Eikon Therapeutics | 487.79M |
| Artiva Biotherapeutics | 486.85M |
| Adlai Nortye | 484.40M |
| Assembly Biosciences | 483.39M |
| Valneva SE | 475.90M |
| Prelude Therapeutics | 467.13M |